Acadian Asset Management LLC Rvl Pharmaceuticals PLC Transaction History

Acadian Asset Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 09, 2020	SELL	$4.82 - $8.77 $745,572 - $1.36 Million	-154,683 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$2.83 - $6.99 $492,852 - $1.22 Million	-174,153 Reduced 52.96%	154,683 $1.04 Million
Q1 2020 May 11, 2020	BUY	$3.18 - $7.0 $491,440 - $1.08 Million	154,541 Added 88.67%	328,836 $1.05 Million
Q4 2019 Feb 06, 2020	BUY	$3.46 - $7.7 $399,207 - $888,410	115,378 Added 195.83%	174,295 $1.22 Million
Q3 2019 Nov 07, 2019	BUY	$2.8 - $3.99 $14,198 - $20,233	5,071 Added 9.42%	58,917 $226,000
Q2 2019 Aug 08, 2019	BUY	$2.34 - $4.28 $92,626 - $169,419	39,584 Added 277.55%	53,846 $206,000
Q1 2019 May 09, 2019	BUY	$3.6 - $8.75 $51,343 - $124,792	14,262 New	14,262 $52,000

92.5K

Ticker RVLP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,150,000
Description
RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. The company is commercializing Upneeq (RVL-1201), an...

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.